Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia. by Lennard, L, Cartwright, C, Wade, R, Richards, S, Vora, A

Sightings of southern resident killer whales in the Salish Sea 1976–2014: the importance of a long-term opportunistic dataset by Olson, JK, Wood, J, Osborne, RW, Barrett-Lennard, L, Larson, S

Get full text

The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia. by Lennard, L, Richards, S, Cartwright, C, Mitchell, C, Lilleyman, J, Vora, A

Thioguanine-related veno-occlusive disease (VOD) of the liver in children with acute lymphoblastic leukaemia (ALL): Report from United Kingdom Medical Research Council (UK MRC) tri... by Vora, A, Mitchell, C, Kinsey, S, Richards, S, Eden, T, Lilleyman, J, Lennard, L

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. by Vora, A, Mitchell, C, Lennard, L, Eden, T, Kinsey, SE, Lilleyman, J, Richards, S

The clinical pharmacology of thioguanine vs. mercaptopurine in ALL97, a randomized trial for the treatment of childhood lymphoblastic leukaemia by Lennard, L, Cartwright, C, Wade, R, Richards, S, Mitchell, C, Kinsey, S, Eden, O, Vora, A

Thioguanine compared with mercaptopurine in childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council randomised trial ALL97. by Lennard, L, Richards, S, Mitchell, C, Cartwright, C, Eden, T, Kinsey, SE, Lilleyman, J, Vora, A

Thioguanine versus mercaptopurine in ALL97: thiopurine metabolism and treatment outcome by Lennard, L, Cartwright, C, Wade, R, Richards, S, Mitchell, C, Kinsey, S, Eden, O, Vora, A

The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozy... by Lennard, L, Cartwright, C, Wade, R, Richards, S, Mitchell, C, Kinsey, S, Eden, T, Lilleyman, J, Vora, A

A synthetic protein as efficient multitarget regulator against complement over-activation by Natalia Ruiz-Molina, Juliana Parsons, Madeleine Müller, Sebastian N. W. Hoernstein, Lennard L. Bohlender, Steffen Pumple, Peter F. Zipfel, Karsten Häffner, Ralf Reski, Eva L. Decker

Get full text

Recombinant Production of MFHR1, A Novel Synthetic Multitarget Complement Inhibitor, in Moss Bioreactors by Oguz Top, Oguz Top, Juliana Parsons, Lennard L. Bohlender, Stefan Michelfelder, Phillipp Kopp, Christian Busch-Steenberg, Sebastian N. W. Hoernstein, Peter F. Zipfel, Karsten Häffner, Ralf Reski, Ralf Reski, Ralf Reski, Eva L. Decker

Get full text

Pooling individual participant data from randomized controlled trials: Exploring potential loss of information. by Lennard L van Wanrooij, Marieke P Hoevenaar-Blom, Nicola Coley, Tiia Ngandu, Yannick Meiller, Juliette Guillemont, Anna Rosenberg, Cathrien R L Beishuizen, Eric P Moll van Charante, Hilkka Soininen, Carol Brayne, Sandrine Andrieu, Miia Kivipelto, Edo Richard

Get full text

Healthy ageing through internet counselling in the elderly (HATICE): a multinational, randomised controlled trial by Edo Richard, MD, Eric P Moll van Charante, MD, Marieke P Hoevenaar-Blom, PhD, Nicola Coley, PhD, Mariagnese Barbera, PhD, Abraham van der Groep, MSc, Yannick Meiller, PhD, Francesca Mangialasche, PhD, Cathrien B Beishuizen, MD, Susan Jongstra, MD, Tessa van Middelaar, MD, Lennard L Van Wanrooij, MSc, Tiia Ngandu, MD, Juliette Guillemont, MSc, Sandrine Andrieu, ProfMD, Carol Brayne, ProfMD, Miia Kivipelto, ProfMD, Hilkka Soininen, ProfMD, Willem A Van Gool, ProfMD

Get full text